Amwill Healthcare shares to debut on BSE SME platform today. Here’s what GMP indicates

February 12, 2025

Amwill Healthcare’s shares will debut on the BSE SME platform with an IPO price of Rs 111 each. The IPO saw moderate investor interest, driven by institutional support. Amwill focuses on derma-cosmetic products, outsourcing manufacturing and distribution to third parties. India’s $14 billion beauty industry is growing rapidly due to online sales and a trend toward personalised products.

More To Explore

Ashok Leyland Q3 Results: Cons PAT surges 36% YoY to Rs 762 crore, revenue rises 8%

The Q3FY25 revenue from operations stood at Rs 11,995 crore, an increase of over 8% from Rs 11,066 crore reported in the corresponding quarter of

February 12, 2025

India’s earnings slowdown cyclical, expect recovery by mid-year: Jonathan Garner

I think there is a minority opinion that this is a more structural slowdown in earnings for India. We do not agree with that. But

February 12, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003